The Valley Desk

NCT01996865 · Interventional trial

Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

Overall registry status Completed

Phase 3

Conditions Lymphoma, Non-Hodgkin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov